Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
CME Activity
Should Diabetes Drugs Require CV Safety Studies Prior to Approval?
Course Director
William D. Carey, MD
Director, Center for Continuing Education
Cleveland Clinic
Cleveland, Ohio
Faculty
Steven E. Nissen, MD, MACC
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Chairman, Department of Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio
Accredited by
Cleveland Clinic Center for Continuing Education
View Activity Materials
Course Description
In clinical trials designed to garner FDA approval of new oral hypoglycemic agents:
1. Describe the history of selection of meaningful endpoints.
2. Discuss the disconnect sometimes observed between measures of glycemic control and cardiovascular events.
3. Summarize the public health implications of failure to include cardiovascular end points in addition to measures of glycemic control.
Activity Details
| Credit Types: | CME |
| Credit Amount: | 0.25 Credits |
| Release Date: | 2011-Nov-16 |
| Expiration Date: | 2013-Nov-16 |
| Estimated Time for Completion: | 15 minutes |
| Registration Required: | No |
| Cost: | Free |
Search
Suggest a CME Activity
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
OpenCME for Publishers
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.
